Cargando…
In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs
Nearly half of severe Hemophilia A (HA) cases are caused by F8 intron 22 inversion (Inv22). This 0.6-Mb inversion splits the 186-kb F8 into two parts with opposite transcription directions. The inverted 5′ part (141 kb) preserves the first 22 exons that are driven by the intrinsic F8 promoter, leadi...
Autores principales: | Wu, Yong, Hu, Zhiqing, Li, Zhuo, Pang, Jialun, Feng, Mai, Hu, Xuyun, Wang, Xiaolin, Lin-Peng, Siyuan, Liu, Bo, Chen, Fangping, Wu, Lingqian, Liang, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705535/ https://www.ncbi.nlm.nih.gov/pubmed/26743572 http://dx.doi.org/10.1038/srep18865 |
Ejemplares similares
-
Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing
por: Hu, Zhiqing, et al.
Publicado: (2023) -
CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B
por: Tang, Qiyu, et al.
Publicado: (2023) -
ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
por: Hu, Zhiqing, et al.
Publicado: (2019) -
Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From F8-Modified iPSCs
por: Qiu, Liyan, et al.
Publicado: (2021) -
Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes
por: Xiao, Rou, et al.
Publicado: (2022)